Clarithromycin (Veterinary Grade)

Product Overview

Clarithromycin is an advanced macrolide antibiotic for veterinary use, derived from erythromycin with improved acid stability and oral bioavailability. Its 14-hydroxy metabolite is also microbiologically active, enhancing its effectiveness against a wider range of pathogens.

Clarithromycin inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit. It demonstrates efficacy against respiratory pathogens, Helicobacter species, and Mycobacteria. Primarily used in companion animal medicine and specialized livestock applications requiring advanced macrolide therapy.

Quality Specifications

Purity	As per USP monograph
Residual Solvents	Compliant with ICH Q3C
Heavy Metals	Compliant with pharmacopoeia limits
GMP Status	Manufactured under GMP conditions

Veterinary Applications

• Companion animal respiratory infections: Treatment of upper and lower respiratory tract infections in dogs and cats
• Canine Helicobacter gastritis: Management of gastric Helicobacter infections
• Feline mycobacterial infections: Treatment of atypical mycobacteriosis in cats
• Specialized poultry applications: Targeted use for specific bacterial pathogens
• Exotic animal medicine: Respiratory and mycobacterial infections in exotic and zoo animals